Phase II evaluation of galactitol in head and neck cancer: A southwest oncology group study

Charles D. Haas; Daniel Lehane; Richard Bottomley

doi:10.1002/mpo.2950110414

Phase II evaluation of galactitol in head and neck cancer: A southwest oncology group study

Charles D. Haas, Daniel Lehane, Richard Bottomley

Department of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

A phase II evaluation of DAG in head and neck cancer patients produced one partial response and one patient with prolonged stable disease from nine fully evaluable patients with squamous carcinomas. One partial response was produced in a patient with anaplastic thyroid carcinoma. No drug deaths or life-threatening toxicity were reported. Further evaluation of DAG in thyroid tumors is warranted.

Original language	English (US)
Pages (from-to)	281-283
Number of pages	3
Journal	Medical and Pediatric Oncology
Volume	11
Issue number	4
DOIs	https://doi.org/10.1002/mpo.2950110414
State	Published - 1983

Keywords

DAG
head and neck
phase II

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Oncology
Cancer Research

Access to Document

10.1002/mpo.2950110414

Cite this

@article{1d3d2260bf724df68d262b4e32f7e59e,

title = "Phase II evaluation of galactitol in head and neck cancer: A southwest oncology group study",

abstract = "A phase II evaluation of DAG in head and neck cancer patients produced one partial response and one patient with prolonged stable disease from nine fully evaluable patients with squamous carcinomas. One partial response was produced in a patient with anaplastic thyroid carcinoma. No drug deaths or life-threatening toxicity were reported. Further evaluation of DAG in thyroid tumors is warranted.",

keywords = "DAG, head and neck, phase II",

author = "Haas, {Charles D.} and Daniel Lehane and Richard Bottomley",

year = "1983",

doi = "10.1002/mpo.2950110414",

language = "English (US)",

volume = "11",

pages = "281--283",

journal = "Medical and Pediatric Oncology",

issn = "0098-1532",

publisher = "John Wiley & Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Phase II evaluation of galactitol in head and neck cancer

T2 - A southwest oncology group study

AU - Haas, Charles D.

AU - Lehane, Daniel

AU - Bottomley, Richard

PY - 1983

Y1 - 1983

N2 - A phase II evaluation of DAG in head and neck cancer patients produced one partial response and one patient with prolonged stable disease from nine fully evaluable patients with squamous carcinomas. One partial response was produced in a patient with anaplastic thyroid carcinoma. No drug deaths or life-threatening toxicity were reported. Further evaluation of DAG in thyroid tumors is warranted.

AB - A phase II evaluation of DAG in head and neck cancer patients produced one partial response and one patient with prolonged stable disease from nine fully evaluable patients with squamous carcinomas. One partial response was produced in a patient with anaplastic thyroid carcinoma. No drug deaths or life-threatening toxicity were reported. Further evaluation of DAG in thyroid tumors is warranted.

KW - DAG

KW - head and neck

KW - phase II

UR - http://www.scopus.com/inward/record.url?scp=0020516089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020516089&partnerID=8YFLogxK

U2 - 10.1002/mpo.2950110414

DO - 10.1002/mpo.2950110414

M3 - Article

C2 - 6888328

AN - SCOPUS:0020516089

SN - 0098-1532

VL - 11

SP - 281

EP - 283

JO - Medical and Pediatric Oncology

JF - Medical and Pediatric Oncology

IS - 4

ER -

Phase II evaluation of galactitol in head and neck cancer: A southwest oncology group study

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this